Position in QURE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,175,000
-$1,036,853 QoQ
Shares Held
500,000
+29.9% QoQ
Ownership
0.793%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Mar 31, 2026CallValue
$20,496,360
CallShares
1,253,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $329,314,446 across 63 Biotechnology names. QURE ranks #12 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
355,000 | $37,417,000 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
4,900,000 | $35,525,000 | |
| 3 | IMUX |
Immunic, Inc.
|
2,450,000 | $27,195,000 | |
| 4 | ANAB |
Anaptysbio, Inc
|
625,000 | $23,108,312 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
2,450,000 | $21,217,000 | |
| 6 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,553,500 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
590,000 | $19,599,800 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
750,000 | $16,320,000 |
All Filings in QURE
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,175,000 | 500,000 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $20,496,360 | 1,253,600 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $9,211,853 | 384,950 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $17,949,893 | 750,100 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $62,455,900 | 1,070,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,912,900 | 1,285,000 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $522,750 | 37,500 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $16,430,000 | 1,550,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $26,931,500 | 1,525,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,120,500 | 1,850,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,512,000 | 1,900,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,270,000 | 1,975,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,461,610 | 1,693,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,568,250 | 1,575,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,840,700 | 1,295,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,013,020 | 1,093,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,957,150 | 1,145,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $25,768,736 | 1,373,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,257,200 | 1,355,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,484,850 | 1,355,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,991,368 | 1,253,200 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,770,473 | 711,355 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,701,492 | 282,516 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,517,964 | 282,516 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $17,342,400 | 480,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $17,678,400 | 480,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $21,628,800 | 480,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $23,250,500 | 490,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||